Novo Holdings A/S - AMICUS THERAPEUTICS INC ownership

AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 215 filers reported holding AMICUS THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.3%.

Quarter-by-quarter ownership
Novo Holdings A/S ownership history of AMICUS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$25,486,144
-3.2%
2,095,9000.0%1.88%
-7.4%
Q2 2023$26,324,504
+13.3%
2,095,9000.0%2.03%
+32.6%
Q1 2023$23,243,531
-9.2%
2,095,9000.0%1.53%
-4.0%
Q4 2022$25,590,939
+16.7%
2,095,900
-0.2%
1.60%
+52.9%
Q3 2022$21,924,000
-22.5%
2,100,000
-20.3%
1.04%
-25.0%
Q2 2022$28,300,000
+16.7%
2,635,000
+2.9%
1.39%
+9.0%
Q1 2022$24,245,000
-18.0%
2,560,2110.0%1.28%
-8.6%
Q4 2021$29,570,000
+20.9%
2,560,2110.0%1.40%
+10.7%
Q3 2021$24,450,000
+26.9%
2,560,211
+28.1%
1.26%
+48.1%
Q2 2021$19,260,000
-0.7%
1,997,880
+1.8%
0.85%
+6.6%
Q1 2021$19,393,000
-50.1%
1,962,880
+16.5%
0.80%
-52.0%
Q4 2020$38,902,000
+18.8%
1,684,795
-27.4%
1.67%
+2.6%
Q3 2020$32,759,000
-6.4%
2,320,0260.0%1.63%
-28.0%
Q2 2020$34,986,000
+63.2%
2,320,0260.0%2.26%
+57.9%
Q1 2020$21,437,000
-5.0%
2,320,026
+0.1%
1.43%
-1.6%
Q4 2019$22,576,000
+21.4%
2,317,8700.0%1.45%
-54.3%
Q3 2019$18,589,000
-35.7%
2,317,8700.0%3.18%
-21.4%
Q2 2019$28,927,000
+13.9%
2,317,870
+24.1%
4.05%
+7.8%
Q1 2019$25,403,000
+42.0%
1,867,8700.0%3.76%
+49.2%
Q4 2018$17,894,000
-10.2%
1,867,870
+13.4%
2.52%
+59.2%
Q3 2018$19,923,000
+18.0%
1,647,870
+52.4%
1.58%
-6.8%
Q2 2018$16,888,0001,081,1811.70%
Other shareholders
AMICUS THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Redmile Group, LLC 21,719,191$226,748,0008.80%
Perceptive Advisors 27,372,917$285,773,0008.29%
Palo Alto Investors LP 9,847,774$102,811,0008.13%
Finepoint Capital LP 1,688,400$17,627,0005.80%
CM Management, LLC 450,000$4,698,0005.24%
Avoro Capital Advisors LLC 26,800,000$279,792,0005.17%
Artal Group S.A. 4,000,000$41,760,0001.78%
Kynam Capital Management, LP 676,849$7,066,0001.49%
Ghost Tree Capital, LLC 500,000$5,220,0001.46%
Boxer Capital, LLC 2,325,000$24,273,0001.36%
View complete list of AMICUS THERAPEUTICS INC shareholders